The sales are contingent on the closure of UnitedHealth’s acquisition of Amedisys, which has been held up after the ...

The companies said they have an agreement to sell home health and hospice locations to BrightSpring Health Services and The ...

Amedisys (NASDAQ:AMED) rose 1% in after hours trading after a divestiture agreement in its planned sale to UnitedHealth (NYSE ...

UnitedHealth Group and Amedisys have found buyers for key divestitures aimed at getting their $3.3 billion merger over the ...

The Pennant Group (Nasdaq: PNTG) is not stopping its plans for growth following the announcement that the company agreed to acquire home health centers ...

Amedisys (Nasdaq: AMED) announced on Thursday that the company has reached agreements to divest home health and hospice care centers to affiliates of the ...

Noah Tong UnitedHealth Group and Amedisys outlined plans to divest a significant number of home health and hospice locations as they seek to close their $3.3 billion merger. In a court filing ...

Amedisys delivers first-quarter top-line growth across three of its segments, namely Home Health, Hospice and High Acuity Care. Although the revenue and EPS for Amedisys (AMED) give a sense of how ...

Amedisys spurned a previous $3.6 billion all-stock bid from infusion company Option Care Health UnitedHealth Group operates home health and hospice locations in 37 states under its LHC Group ...

MilliporeSigma says the extra fees, which will take effect Monday, are a direct response to President Donald Trump's tariffs. The company is owned by Merck KGaA, which is based in Germany.

The DOJ filed its lawsuit in November arguing UnitedHealth’s buy of Amedisys, one of the largest home health and hospice providers in the U.S., would raise prices for consumers in more than 20 ...

UnitedHealth’s health services unit Optum notched the $3.3 billion deal to acquire Amedisys in summer 2023, beating out Option Care Health to buy the Baton Rogue, Louisiana home care provider.